Clinical Trials Directory

Trials / Completed

CompletedNCT03204968

The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Otto Wagner Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Systemic inflammation is a potentially debilitating complication of thoracic surgeries that can result in significant physical and economic morbidity for afflicted patients. There is compelling evidence for the role of central nervous system in the regulation of systemic inflammatory responses through humoral mechanisms. Activation of afferent vagus nerve fibers by cytokines triggers anti-inflammatory responses. Direct electrical stimulation of the peripheral vagus nerve in vivo during lethal endotoxemia in rats inhibited Tumor necrosis factor (TNF) synthesis in liver preventing the development of shock. The vagal regulatory role of systemic inflammation after lung lobectomy is unknown.

Conditions

Interventions

TypeNameDescription
DEVICEVagus nerve stimulationtranscutaneous Intermittent stimulation of the vagus nerve using neurostimulator V (Ducest®, Germany)

Timeline

Start date
2015-12-01
Primary completion
2016-06-05
Completion
2017-06-01
First posted
2017-07-02
Last updated
2017-07-02

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03204968. Inclusion in this directory is not an endorsement.

The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy (NCT03204968) · Clinical Trials Directory